The London-based European Medicines Agency said it would review the suspension of Bextra, which was first suspended in Europe and the United States in April, within one year.
Wednesday, June 29, 2005
Bextra: Still suspended in Europe
Europe's drug agency concluded a review of COX-2 painkillers, and said on June 27, 2005 it will recommend the continued suspension of Pfizer Inc.'s Bextra drug.
